Endo International Q3 2016 Financial Results Presentation

Endo International plc presents Q3 2016 financial results covering business unit performance across U.S. branded pharmaceuticals, international pharmaceuticals, and U.S. generic pharmaceuticals. The presentation includes strategic updates, 2017 market environment analysis, and corporate planning overview.